World Lifestyle Archives | Page 7 of 417 | Be Korea-savvy

Archive by category World Lifestyle

Solutions to stop a global crisis: “Building Safe Futures: Solutions to End Childhood Sexual Violence” provides a roadmap to end childhood sexual violence

Solutions to stop a global crisis: “Building Safe Futures: Solutions to End Childhood Sexual Violence” provides a roadmap to end childhood sexual violence

The new report from Safe Futures Hub calls for practical action to protect children worldwide Cape Town, South Africa, Oct. 23, 2024 (Korea Bizwire) – Safe Futures Hub, a joint initiative of  Together for Girls, WeProtect Global Alliance, and the Sexual Violence Research Initiative (SVRI) has today launched “Building Safe Futures: Solutions to end childhood sexual violence.” This comprehensive evidence [...]

EBC Financial Group and the University of Oxford’s Department of Economics Announce WERD Episode on Macroeconomics and Climate

EBC Financial Group and the University of Oxford’s Department of Economics Announce WERD Episode on Macroeconomics and Climate

OXFORD, United Kingdom, Oct. 23, 2024 (Korea Bizwire) – EBC Financial Group (EBC) is proud to announce its continued collaboration with the University of Oxford’s Department of Economics for the 2024-2025 edition of the acclaimed “What Economists Really Do” (WERD) webinar series. The upcoming event will be the first WERD event to feature a dedicated panel discussion [...]

Panopto Adds Generative AI Text-to-Video Creation Capabilities Through Its Acquisition of Elai

Panopto Adds Generative AI Text-to-Video Creation Capabilities Through Its Acquisition of Elai

Authentic custom avatars, verified voice cloning and guided storyboard scriptwriting facilitate cost-effective, scalable and accessible video training and learning PITTSBURGH, Oct. 23, 2024 (Korea Bizwire) — Today, Panopto, the global leader in AI-powered video creation and management solutions, announced its acquisition of Elai, a revolutionary AI text-to-video platform that quickly generates engaging video content for learning with [...]

Sportradar Deepens Official Partnership with NBA with Launch of Innovative, Value-Add Fan Engagement Solutions

Sportradar Deepens Official Partnership with NBA with Launch of Innovative, Value-Add Fan Engagement Solutions

New and Expanded Offerings Foster Personalization and Deeper Fan Engagement for NBA NEW YORK and ST. GALLEN, Switzerland, Oct. 22, 2024 (Korea Bizwire) – Sportradar (NASDAQ: SRAD) is enhancing its partnership with the NBA this season through the introduction of a suite of innovative fan engagement solutions fuelling the passion of the league’s two billion [...]

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection

REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks catalytic activity of the toxin’s innate glucosyltransferase in order to inhibit the toxin produced by C. diff. in the gastrointestinal tract. There are up to 175,000 cases of recurrent C. diff. each [...]

Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)

Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)

Approval of SELARSDI 130 mg/26 mL in a single-dose vial for intravenous infusion expands label to include treatment of adults with Crohn’s disease and ulcerative colitis The FDA previously approved SELARSDI 45 mg/0.5 mL and 90 mg/mL in a single-dose prefilled syringe for subcutaneous injection in April 2024 SELARSDI’s U.S. launch for all indications is [...]

UPDATE – Politecnico di Torino as a Driving Force in Space Research

UPDATE – Politecnico di Torino as a Driving Force in Space Research

The University stars at the International Astronautical Congress 2024 in Milan Politecnico di Torino proves its prominent role in the aerospace and aeronautics research landscape with a solid presence at the IAC conference, Oct. 14-18 A stage of IAC’s Astronauts Chapter will be hosted on Tuesday, Oct. 15, at 3 p.m. in Politecnico’s Aula Magna, [...]

XO Strengthens World’s Largest Private Aviation Network and Boosts Instant Booking Options by Over 55%

XO Strengthens World’s Largest Private Aviation Network and Boosts Instant Booking Options by Over 55%

55% more private jets available with instant booking options Even more preferred pricing on high-demand routes First-time flyers to earn flight credits when utilizing the instant booking platform New York, October 21, 2024: XO, the private aviation network of the Vista group, announces major advancements in private aircraft booking on its platform. Responding to this marked [...]

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers

Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW171 in treatment of ovarian cancer, non-small cell lung cancer (NSCLC), and other mesothelin (MSLN) expressing cancers VANCOUVER, British Columbia, Oct. 21, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to [...]